Neal Mody
Managing Director

In 2014, Neal founded Zoic to address the systematic underfunding of early-stage health technology startups, and focus on identifying, funding, and developing the next era of health. Neal works closely with his portfolio companies to provide strategic and operational value beyond capital, supervising workshops to build a large-scale IP development strategy, and codeveloping deals with potential strategic acquirers.

Neal has over 15 years of successful experience in the tech startup space.  In 2007, Neal co-founded of Ambature, a superconductor company leading the charge towards room-temperature superconductors, a key technology to enabling quantum computers and fusion reactors. As founding CEO, Neal led the company to raise $20M in funding and create 3,700 patent claims, accounting for more than half of patents in the world in the field. In 2019, Neal co-founded HDT Bio, an RNA-based immunotherapy company that has received hundreds of millions in government funding to advance the battle against the world’s deadliest infectious diseases and cancer, and distribute their advances to patients globally.

Neal’s accomplishments at Ambature and HDT have made him a valuable and trusted source of advice for other CEOs. He has served on the Board of Directors of 10 other startups and has offered guidance to over 100 CEOs through his mentoring role at Creative Destruction Labs.